Aller au contenu principal
Profil bibliographique

Khawaja Abdul Rehman

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

40Publications signalées
13Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Head and Neck Cancer StudiesLiver Disease Diagnosis and TreatmentEndometrial and Cervical Cancer TreatmentsColorectal and Anal CarcinomasBreast Cancer Treatment Studies

Les publications récentes

Accès ouvert 2026 article OpenAlex

Trends and disparities in hepatorenal syndrome related mortality among adults ≥15 years in the United States: A retrospective observational study

Khawaja Abdul Rehman, Syed Sarmad Javaid, F. N. U. Pirih, Maliha Malik et autres

Hepatorenal syndrome (HRS) is characterized by severe renal dysfunction associated with decompensated liver cirrhosis, leading to high morbidity and mortality. This study aims to assess disparities in HRS-related mortality stratified by sex, race/ethnicity, and geographic location in the U.S. We analyzed death …

pk, us, np (code pays fourni par la source)

0 citations Medicine
2026 review OpenAlex

Efficacy and safety of adjuvant chemotherapy for locally advanced cervical carcinoma: an updated Systematic review and meta-analysis

Eeshal Fatima, Khawaja Abdul Rehman, Obaid Ur Rehman, Noman Salih et autres

This meta-analysis assessed the latest clinical efficacy and safety of adjuvant chemotherapy (ACT) after concurrent chemoradiotherapy (CCRT) compared to CCRT alone for locally advanced cervical cancer. Studies were pooled via random effects model. Overall survival (OS; risk of death from any cause) …

pk, us, qa (code pays fourni par la source)

0 citations Journal of Chemotherapy
Accès ouvert 2026 article OpenAlex

Efficacy and safety of adjuvant chemotherapy for locally advanced cervical carcinoma: an updated Systematic review and meta-analysis

Eeshal Fatima, Khawaja Abdul Rehman, Obaid Ur Rehman, Noman Salih et autres

This meta-analysis assessed the latest clinical efficacy and safety of adjuvant chemotherapy (ACT) after concurrent chemoradiotherapy (CCRT) compared to CCRT alone for locally advanced cervical cancer. Studies were pooled via random effects model. Overall survival (OS; risk of death from any cause) …

0 citations Figshare
Accès ouvert 2026 article OpenAlex

Efficacy and safety of adjuvant chemotherapy for locally advanced cervical carcinoma: an updated Systematic review and meta-analysis

Eeshal Fatima, Khawaja Abdul Rehman, Obaid Ur Rehman, Noman Salih et autres

This meta-analysis assessed the latest clinical efficacy and safety of adjuvant chemotherapy (ACT) after concurrent chemoradiotherapy (CCRT) compared to CCRT alone for locally advanced cervical cancer. Studies were pooled via random effects model. Overall survival (OS; risk of death from any cause) …

0 citations Figshare
2025 conference-abstract OpenAlex

Abstract 4368013: Trends in Stroke and Cancer-Related Mortality in the United States from 1999 to 2023

Khawaja Abdul Rehman, Areej Javeid, Javeria Javeid, Rohab Sohail et autres

Background: Stroke is the fifth leading cause of mortality in the United States (US), with diverse etiologies. Evidence suggests that cancer is a significant predisposing factor, with studies demonstrating an elevated risk of stroke in cancer patients. However, mortality trends due to …

pk, us (code pays fourni par la source)

0 citations Circulation
2025 conference-abstract OpenAlex

Abstract 4371603: Cerebral Embolic Protection in TAVI: Does It Improve Outcomes? A Comprehensive Meta-Analysis and Trial Sequential Analysis

Muhammad Faizan Ali, Khawaja Abdul Rehman, Mohamed Fawzi Hemida, Ashraf Ahmed et autres

Background: Previous evidence from randomized controlled trials (RCTs) on cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been inconclusive. The recent PROTECT TAVI trial, the largest RCT to date, offers new data to reassess outcomes. We conducted a comprehensive …

pk, Égypte, us (code pays fourni par la source)

0 citations Circulation
2025 conference-abstract OpenAlex

Abstract FR522: Temporal Trends and Disparities in Mortality of Patients with Hypertension and Hepatobiliary Cancer in the United States: A Retrospective Analysis from 1999 to 2020

Eeshal Fatima, Khawaja Abdul Rehman, Adan Irfan, Umar Akram et autres

Background: Hepatobiliary cancers (HBC) contribute to approximately 13% of global cancer-related mortality. Among these, primary liver cancer remains the most prevalent, with over 41,000 new cases projected in 2024. Emerging evidence suggests that hypertension is a potential risk factor for HBC, with …

pk, us (code pays fourni par la source)

0 citations Hypertension
2025 conference-abstract OpenAlex

Efficacy and safety of adjuvant chemotherapy for locally advanced cervical carcinoma: An updated systematic review and meta-analysis of individual patient data and aggregate data.

Khawaja Abdul Rehman, Eeshal Fatima, Muhammad Riyyan, Obaid Ur Rehman et autres

e17518 Background: Cervical cancer is the fourth most common cancer among women globally. Adjuvant chemotherapy (ACT) is added to concurrent chemo-radiotherapy (CCRT) for the treatment of locally advanced cervical cancer (LACC) to reduce recurrence and mortality rates by targeting residual malignant cells. …

pk, us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Temporal and regional mortality trends in patients with hypertension and hepatobiliary cancer in the United States from 1999 to 2020.

Zain Ali Nadeem, Eeshal Fatima, Khawaja Abdul Rehman, Umar Akram et autres

e16310 Background: Hepatobiliary cancers (HBC) represent a diverse group of malignancies, contributing to approximately 13% of global cancer-related mortality. Among these, primary liver cancer remains the most prevalent, with over 41,000 new cases projected in 2024. Emerging evidence suggests that hypertension (HTN) …

pk, us (code pays fourni par la source)

0 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.